A novel LUAD prognosis prediction model based on immune checkpoint-related lncRNAs

Lung adenocarcinoma (LUAD) is a malignant disease with an extremely poor prognosis, and there is currently a lack of clinical methods for early diagnosis and precise treatment and management. With the deepening of tumor research, more and more attention has been paid to the role of immune checkpoint...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yang, Yu, Mingyang, Cheng, Xuechao, Zhang, Xingshu, Luo, Qian, Liao, Sijin, Chen, Zhongzheng, Zheng, Jianhao, Long, Kaijun, Wu, Xingwei, Qu, Wendong, Gong, Ming, Song, Yongxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533213/
https://www.ncbi.nlm.nih.gov/pubmed/36212122
http://dx.doi.org/10.3389/fgene.2022.1016449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533213/
https://www.ncbi.nlm.nih.gov/pubmed/36212122
http://dx.doi.org/10.3389/fgene.2022.1016449

Ejemplares similares